From: Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
Phase constant
Blood*(h)
Plasma*(h)
π
0.14 ± 0.16
0.12 ± 0.11
α
1.5 ± 0.7
1.3 ± 0.8
β
15 ± 8
21 ± 8